Regimen rifampicin isoniazid. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Organisms5

Mycobacterium tuberculosis Mycobacteriophages Mycobacterium smegmatis Mycobacterium Mycobacterium kansasii

Diseases12

Tuberculosis, Multidrug-Resistant Tuberculosis Tuberculosis, Pulmonary Latent Tuberculosis Tuberculosis, Miliary Mycobacterium Infections, Nontuberculous Tuberculosis, Lymph Node Extensively Drug-Resistant Tuberculosis Drug-Induced Liver Injury HIV Infections Tuberculosis, Osteoarticular AIDS-Related Opportunistic Infections

Chemicals and Drugs36

Isoniazid Rifampin Antitubercular Agents Antibiotics, Antitubercular Ethambutol Pyrazinamide Ethionamide Streptomycin Aminosalicylic Acid Anti-Bacterial Agents Aminosalicylic Acids Rifamycins Catalase Clofazimine Rifabutin Isonicotinic Acids Bacterial Proteins Aza Compounds Thioacetazone Leprostatic Agents DNA-Directed RNA Polymerases Mycolic Acids Cytochrome P-450 CYP3A Ofloxacin Quinolines Oxidoreductases DNA, Bacterial Receptors, Steroid Arylamine N-Acetyltransferase Hydrazines Drug Combinations Nitrate Reductase Oxazines Cytochrome P-450 CYP2E1 Cytochrome P-450 Enzyme System Diarylquinolines

Analytical, Diagnostic and Therapeutic Techniques and Equipment10

Microbial Sensitivity Tests Drug Therapy, Combination Treatment Outcome Drug Administration Schedule Colony Count, Microbial Tuberculin Test Area Under Curve Directly Observed Therapy Antineoplastic Combined Chemotherapy Protocols Administration, Oral

Phenomena and Processes10

Drug Resistance, Bacterial Drug Resistance, Multiple, Bacterial Drug Resistance, Microbial Drug Interactions Time Factors Area Under Curve Mutation Half-Life Enzyme Induction Dose-Response Relationship, Drug

Health Care2

Treatment Outcome Area Under Curve

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Health Care Geographicals

Isoniazid Rifampin Antitubercular Agents Antibiotics, Antitubercular Mycobacterium tuberculosis Ethambutol Pyrazinamide Tuberculosis, Multidrug-Resistant Tuberculosis Tuberculosis, Pulmonary Microbial Sensitivity Tests Ethionamide Streptomycin Drug Resistance, Bacterial Drug Therapy, Combination Aminosalicylic Acid Drug Resistance, Multiple, Bacterial Anti-Bacterial Agents Aminosalicylic Acids Rifamycins Drug Resistance, Microbial Treatment Outcome Drug Interactions Catalase Drug Administration Schedule Mycobacteriophages Clofazimine Rifabutin Isonicotinic Acids Mycobacterium smegmatis Bacterial Proteins Mycobacterium Sputum Colony Count, Microbial Aza Compounds Latent Tuberculosis Thioacetazone Time Factors Tuberculosis, Miliary Leprostatic Agents DNA-Directed RNA Polymerases Mycolic Acids Cytochrome P-450 CYP3A Mycobacterium Infections, Nontuberculous Ofloxacin Tuberculosis, Lymph Node Tuberculin Test Area Under Curve Quinolines Extensively Drug-Resistant Tuberculosis Drug-Induced Liver Injury HIV Infections Directly Observed Therapy Oxidoreductases DNA, Bacterial Mutation Half-Life South Africa Antineoplastic Combined Chemotherapy Protocols Administration, Oral Tuberculosis, Osteoarticular Enzyme Induction Receptors, Steroid Arylamine N-Acetyltransferase Hydrazines Mycobacterium kansasii Dose-Response Relationship, Drug Drug Combinations Nitrate Reductase AIDS-Related Opportunistic Infections Oxazines Cytochrome P-450 CYP2E1 Cytochrome P-450 Enzyme System Diarylquinolines

No FAQ available that match "regimen rifampicin isoniazid"